Clinical Trial Update: Dose Optimization of MDMA-Assisted Therapy for PTSD [Phase 2]

View source ↗

Summary

Phase 2 trial investigating dose optimization of MDMA-assisted therapy for posttraumatic stress disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Bronx VA Medical Center | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: RECRUITING